Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Fabio Fuligni

Showing results (11-20 of 45) with videos related to

Pageof 5
Sort By:
Clinical Sarcoma Research|August 22, 2014
Dystrophin deregulation is associated with tumor progression in KIT/PDGFRA mutant gastrointestinal stromal tumorsMaria A Pantaleo, Annalisa Astolfi, Milena Urbini, et al.
Cancer Discovery|November 6, 2013
Defective stromal remodeling and neutrophil extracellular traps in lymphoid tissues favor the transition from autoimmunity to lymphomaSabina Sangaletti, Claudio Tripodo, Caterina Vitali, et al.
Oncotarget|December 30, 2014
Constitutive activation of the DNA damage response pathway as a novel therapeutic target in diffuse large B-cell lymphomaEnrico Derenzini, Claudio Agostinelli, Enrica Imbrogno, et al.
The American Journal of Surgical Pathology|August 15, 2014
Intracellular TCR-signaling pathway: novel markers for lymphoma diagnosis and potential therapeutic targetsClaudio Agostinelli, Hasan Rizvi, Jennifer Paterson, et al.
Metabolic Engineering|August 24, 2014
Comparative genomics revealed key molecular targets to rapidly convert a reference rifamycin-producing bacterial strain into an overproducer by genetic engineeringClelia Peano, Fabrizio Damiano, Mattia Forcato, et al.
Frontiers in Oncology|May 31, 2021
Clinical Relevance of ABCB1, ABCG2, and ABCC2 Gene Polymorphisms in Chronic Myeloid Leukemia Patients Treated With NilotinibFederica Loscocco, Giuseppe Visani, Annamaria Ruzzo, et al.
Frontiers in Microbiology|January 8, 2015
Molecular signature of Epstein Barr virus-positive Burkitt lymphoma and post-transplant lymphoproliferative disorder suggest different roles for Epstein Barr virusMohsen Navari, Fabio Fuligni, Maria A Laginestra, et al.
Biomed Research International|January 7, 2014
Hsa-miR-15a and Hsa-miR-16-1 expression is not related to proliferation centers abundance and other prognostic factors in chronic lymphocytic leukemiaMaura Rossi, Fabio Fuligni, Maria Ciccone, et al.
BMC Cancer|October 11, 2015
Burkitt lymphoma beyond MYC translocation: N-MYC and DNA methyltransferases dysregulationGiulia De Falco, Maria Raffaella Ambrosio, Fabio Fuligni, et al.
Pediatric Hematology and Oncology|February 27, 2019
Aggressive embryonal rhabdomyosarcoma in a 3-month-old boy: A clinical and molecular analysisSamuele Renzi, Karin Langenberg-Ververgaert, Fabio Fuligni, et al.
Pageof 5

Showing results (11-20 of 45) with videos related to

Sort By:
Pageof 5
Clinical Sarcoma Research|August 22, 2014
Dystrophin deregulation is associated with tumor progression in KIT/PDGFRA mutant gastrointestinal stromal tumorsMaria A Pantaleo, Annalisa Astolfi, Milena Urbini, et al.
Cancer Discovery|November 6, 2013
Defective stromal remodeling and neutrophil extracellular traps in lymphoid tissues favor the transition from autoimmunity to lymphomaSabina Sangaletti, Claudio Tripodo, Caterina Vitali, et al.
Oncotarget|December 30, 2014
Constitutive activation of the DNA damage response pathway as a novel therapeutic target in diffuse large B-cell lymphomaEnrico Derenzini, Claudio Agostinelli, Enrica Imbrogno, et al.
The American Journal of Surgical Pathology|August 15, 2014
Intracellular TCR-signaling pathway: novel markers for lymphoma diagnosis and potential therapeutic targetsClaudio Agostinelli, Hasan Rizvi, Jennifer Paterson, et al.
Metabolic Engineering|August 24, 2014
Comparative genomics revealed key molecular targets to rapidly convert a reference rifamycin-producing bacterial strain into an overproducer by genetic engineeringClelia Peano, Fabrizio Damiano, Mattia Forcato, et al.
Frontiers in Oncology|May 31, 2021
Clinical Relevance of ABCB1, ABCG2, and ABCC2 Gene Polymorphisms in Chronic Myeloid Leukemia Patients Treated With NilotinibFederica Loscocco, Giuseppe Visani, Annamaria Ruzzo, et al.
Frontiers in Microbiology|January 8, 2015
Molecular signature of Epstein Barr virus-positive Burkitt lymphoma and post-transplant lymphoproliferative disorder suggest different roles for Epstein Barr virusMohsen Navari, Fabio Fuligni, Maria A Laginestra, et al.
Biomed Research International|January 7, 2014
Hsa-miR-15a and Hsa-miR-16-1 expression is not related to proliferation centers abundance and other prognostic factors in chronic lymphocytic leukemiaMaura Rossi, Fabio Fuligni, Maria Ciccone, et al.
BMC Cancer|October 11, 2015
Burkitt lymphoma beyond MYC translocation: N-MYC and DNA methyltransferases dysregulationGiulia De Falco, Maria Raffaella Ambrosio, Fabio Fuligni, et al.
Pediatric Hematology and Oncology|February 27, 2019
Aggressive embryonal rhabdomyosarcoma in a 3-month-old boy: A clinical and molecular analysisSamuele Renzi, Karin Langenberg-Ververgaert, Fabio Fuligni, et al.
Pageof 5